Gargouri, Ali Faouzi, 19..-....
VIAF ID: 198932686 ( Personal )
Permalink: http://viaf.org/viaf/198932686
Preferred Forms
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
ALK is a novel dependence receptor : study of the mechanism of ALK proapoptotic effect. | |
ALK, un nouveau récepteur à dépendance : étude des mécanismes de son effet pro-apoptotique | |
Application of hydrothermal and enzymatic treatments of solubilisation and saccharification of hemicellulosic fraction for sugarcane bagasse valorization. | |
Criblage de la diversité fongique marine visant à identifier de nouvelles oxydases pour les biotechnologies et le développement durable | |
Ecologie microbienne de produits végétaux : Adaptation de traitements assainissants pour la valorisation de ces produits | |
The Effect of TRL-Agonists on the Production of ROS by NADPH Oxidase of Human Neutrophils. | |
Etude biophysique de la régénération de neurones périphériques | |
Etude de l'équilibre protéolytique comme nouvelle stratégie thérapeutique contre le syndrome de l'intestin irritable | |
Microbial ecology of vegetable matter : Adaptation of cleaning treatments for the valuation of these products. | |
New strategy for plant improvement productivity under stress conditions via a better control of cell cycle. | |
Nouvelle stratégie d'amélioration de la productivité végétale en condition de stress environnemental via un meilleur contrôle du cycle cellulaire | |
Physiological and molecular dissection of phytic acid role in response of plant to environmental stress. | |
Plasticity of the genomes of cereal aphids and their host plant : in silico and in vitro analyses of Tc1-mariner-IS630 and piggyBac superfamilies of transposable elements. | |
The role of the immune system and the Nitric-Oxide Synthase type 2 in a new mouse model of rapidly evolving melanoma : implications for human cancers. | |
Screening of marine fungal diversity to identify new oxidases for biotechnologies and sustainable developments. | |
Study of proteolytic balance as a new therapeutic strategy for irritable bowel syndrome. |